Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy. [electronic resource]
Producer: 20150814Description: 785-92 p. digitalISSN:- 2005-6648
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers, Tumor -- analysis
- Chi-Square Distribution
- Cyclophosphamide -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Lymphoma, Large B-Cell, Diffuse -- chemistry
- Male
- Middle Aged
- Multivariate Analysis
- NF-kappa B -- analysis
- Neoplasm Staging
- Predictive Value of Tests
- Prednisone -- administration & dosage
- Proportional Hazards Models
- Receptors, CXCR4 -- analysis
- Retrospective Studies
- Risk Factors
- Rituximab
- Time Factors
- Treatment Outcome
- Vincristine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.